CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | Rodgers Richard J Director | Grant or award | +24,367 | 343,022 | ||
| 2025-04-30 | Rodgers Richard J Director | Grant or award | +79,504 | 318,655 | ||
| 2025-04-30 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2024-06-11 | Rodgers Richard J Director | Grant or award | +41,143 | 239,151 | ||
| 2024-06-11 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-01-01 | Rodgers Richard J Director | Grant or award | +24,762 | 198,008 | ||
| 2023-11-01 | Rodgers Richard J Director | Grant or award | +35,000 | 173,246 | ||
| 2023-04-19 | Rodgers Richard J Interim CEO and President | Grant or award | +50,000 | 138,246 | ||
| 2023-01-11 | Rodgers Richard J Director | Grant or award | +20,822 | 88,246 | ||
| 2022-10-03 | Rodgers Richard J Director | Option exercise | +3,148 | $0.00 | $0 | 67,424 |
| 2022-10-03 | Rodgers Richard J Director | Option exercise · Series B Warrant (right to buy) | −3,148 | 0 | ||
| 2022-07-01 | Rodgers Richard J Director | Grant or award | +7,812 | 48,435 | ||
| 2022-07-01 | Rodgers Richard J Director | Grant or award | +15,841 | 64,276 | ||
| 2022-06-13 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-04-01 | Rodgers Richard J Director | Grant or award | +4,629 | 40,623 | ||
| 2022-01-03 | Rodgers Richard J Director | Grant or award | +4,021 | 35,994 | ||
| 2021-10-01 | Rodgers Richard J Director | Grant or award | +2,912 | 31,973 | ||
| 2021-07-01 | Rodgers Richard J Director | Grant or award | +2,840 | 29,061 | ||
| 2021-06-07 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-04-01 | Rodgers Richard J Director | Grant or award | +2,581 | 26,221 |
Page 1 of 2 · 26 trades